Skip to main content
. 2002 Nov;76(22):11775–11779. doi: 10.1128/JVI.76.22.11775-11779.2002

TABLE 2.

Neutralization of E2 binding to target cell and of VSV/HCV entry into hepatoma cells by the human recombinant anti-E2 Fabs used in this study

Fab clone 50% NOB concentration (μg/ml) (relative level of NOB activity)a Effect on VSV/HCV infection
e8 >40 (none) None
e20 3 (high) None
e137 40 (low) Inhibition
e301 3 (high) Strong inhibition
e509 <0.035 (highest) Enhancement
a

NOB activity data are derived from data previously published (7).